Sennosides and Tumor - a phase IV clinical study of FDA data

Summary:

Tumor is reported as a side effect among people who take Sennosides (senna), especially for people who are male, 60+ old, also take Amlodipine, and have Neuroendocrine tumor.

The phase IV clinical study analyzes which people have Tumor when taking Sennosides. It is created by eHealthMe based on reports of 8,186 people who have side effects when taking Sennosides from the FDA, and is updated regularly.

What is Sennosides?

Sennosides has active ingredients of senna. It is often used in constipation. eHealthMe is studying from 8,247 Sennosides users. Check the latest studies of Sennosides.

What is Tumor?

Tumor is found to be associated with 1,407 drugs and 1,707 conditions by eHealthMe. Check the latest studies of Tumor.

On Aug, 10, 2026

8,186 people reported to have side effects when taking Sennosides.
Among them, 21 people (0.26%) have Tumor.

Among these 21 people:

What is the gender of people who have Tumor when taking Sennosides? *

female: 41.18 %
male: 58.82 %

What is the age of people who have Tumor when taking Sennosides? *

What are other drugs people take besides Sennosides? *

What are other side effects people have besides Tumor? *

Fatigue (feeling of tiredness): 14 people, 66.67%
Nausea (feeling of having an urge to vomit): 11 people, 52.38%
Weight Decreased: 10 people, 47.62%
Weakness: 9 people, 42.86%
Chest Pain: 9 people, 42.86%
Oedema Peripheral (superficial swelling): 8 people, 38.10%
Abdominal Pain: 7 people, 33.33%
Herpes Zoster: 7 people, 33.33%
Heart Rate Increased: 7 people, 33.33%
High Blood Pressure: 6 people, 28.57%

What are the existing conditions these people have? *

Pain: 5 people, 23.81%
Neuroendocrine Tumor: 5 people, 23.81%
Insomnia (sleeplessness): 3 people, 14.29%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 14.29%
Immune System Disorder: 3 people, 14.29%
Hyperparathyroidism Secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary): 2 people, 9.52%
Prostate Cancer Metastatic: 2 people, 9.52%
High Blood Cholesterol: 1 person, 4.76%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 4.76%
Hypoaesthesia (reduced sense of touch or sensation): 1 person, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Sennosides and have Tumor?

- Check whether Tumor is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Sennosides:

Sennosides (8,247 reports)

Tumor treatments and more:

Tumor (38,734 reports)

Browse all side effects of Sennosides:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Tumor:

Tumor (1,407 drugs)

Browse all the conditions that are associated with Tumor:

Tumor (1,707 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on senna (the active ingredients of Sennosides) and Sennosides (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.